Combined SSTR2-targeted Analogue with 177Lu-DOTATATE radionuclide and octreotide therapy for refractory meningioma: a case report.

Saved in:
Bibliographic Details
Title: Combined SSTR2-targeted Analogue with 177Lu-DOTATATE radionuclide and octreotide therapy for refractory meningioma: a case report.
Authors: Yuen CA; Department of Neurology, Division of Neuro-oncology, University of California, Irvine, Irvine, CA, United States.; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, United States., Jafarvand M; Department of Radiology, Division of Nuclear Medicine, University of California, Irvine, Irvine, CA, United States., Kamson DO; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, United States.; Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, MD, United States., Chu E; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, United States.; Department of Radiology, Division of Neuroradiology, University of California, Irvine, Irvine, CA, United States., Soun JE; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, United States.; Department of Radiology, Division of Neuroradiology, University of California, Irvine, Irvine, CA, United States., Yong WH; Department of Pathology, Division of Neuropathology, University of California, Irvine, Irvine, CA, United States., Hsu FP; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, United States.; Department of Neurosurgery, University of California, Irvine, Irvine, CA, United States., Bow H; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, United States.; Department of Neurosurgery, University of California, Irvine, Irvine, CA, United States., Zheng M; UC Irvine Charlie Dunlop School of Biological Sciences, Irvine, Irvine, CA, United States., Srinivas SM; Department of Radiology, Division of Nuclear Medicine, University of California, Irvine, Irvine, CA, United States.
Source: Frontiers in oncology [Front Oncol] 2026 Jun 11; Vol. 16, pp. 1820428. Date of Electronic Publication: 2026 Jun 11 (Print Publication: 2026).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2026.1820428